ABOUT US

We are a forward-thinking, mid-size early phase contract research organization, in Canada and the U.S., offering biopharmaceutical companies of all sizes a proven, flexible approach to early drug development, including preclinical safety testing, clinical pharmacology (Phase I to Phase II), bioanalysis (preclinical to Phase IV), research services, and manufacturing and analytical services. Focused on your success … always available and always looking ahead. Moving in unison to deliver big impact with a personal touch.

More About Us

...working with Altasciences has been excellent, from both a bioanalytical, and a bioavailability study perspective. We are really impressed with their planning and execution abilities – I would not consider another provider for future work.

James M Mackay, President and Chief Executive Officer, Aristea Therapeutics

RESOURCE CENTER

Blog - Protocol Design Concepts in Phase I Ethnobridging Clinical Trials

Read the blog

Protocol Design Concepts in Phase I Ethnobridging Clinical Trials

In Phase I ethnobridging clinical trials, there are three primary protocol design concepts utilized. These concepts align the strategy with global clinical development and measure key factors necessary for meeting the unique needs of the Sponsor.

View All News & Events Go to Resource Center

SELECT A CATEGORY BELOW:

The Altascientist Scientific journal
eBulletins Highlights on key topics
Newsletters Latest industry and corporate news
Scientific Publications Posters, case studies and abstracts
Blog
Videos

Careers

Join our team! Work at Altasciences - View all clinical job postings

Bring your talents and forward-thinking approach to Altasciences and help us develop medicines for those who need them, faster. We have a number of opportunities for you to explore.

Learn More

NEWS & EVENTS

A starry night with chemical-like webbing and the words "Altasciences Acquires WCCT Global" written over top.

Press Release

Altasciences Acquires WCCT Global

Altasciences is expanding its current clinical operations in Montreal and Kansas City with the addition of a clinical CRO on the U.S.A.'s West Coast. Click below to read more about the acquisition of WCCT Global.

View All News & Events Go to Resource Center

SELECT A CATEGORY BELOW:

Altasciences Events
Press Releases
Altasciences in the News
Press Kit
Webinars / Podcasts

Our Solutions

NEWSLETTERS

September 2020

Newsletter

September 2020

Oct 1, 2020

Examine our bioanalytical assay list, new scientific publications, webinars, podcasts, and more, covering our full-service preclinical, clinical and manufacturing solutions…

June 2020

Newsletter

June 2020

Jun 25, 2020

Newsletter ― Includes exclusive access to our new podcasts!

March 2020

Newsletter

March 2020

Mar 30, 2020

Newly Validated Assays, Scientific Posters, Case Studies, and More ― It’s all in our Newsletter!

December 2019

Newsletter

December 2019

Dec 2, 2019

A FIH case study, scientific posters, webinars, and our latest validated assays.

August 2019

Newsletter

August 2019

Aug 28, 2019

A case study with cannabis, scientific posters, upcoming webinars, and more!

May 2019

Newsletter

May 2019

May 29, 2019

A recent case study, an upcoming webinar and more

March 2019

Newsletter

March 2019

Mar 29, 2019

Bold new look, how to overcome bioanalytical challenges, and case studies on hybrid medicines, 505(b)(2), and drug interactions

2021 © Altasciences. All Rights Reserved.

Cookie Policy | Privacy Policy